Re: Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer

被引：10
|
作者：
Nielsen, Torsten O.
Cheang, Maggie C. U.
Chia, Stephen K.
Voduc, David
Gao, Dongxia
Leung, Samuel
Bernard, Philip S.
Perou, Charles M.
Ellis, Matthew J.
机构：
来源：
JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2009年 / 101卷 / 24期
关键词：
ESTROGEN-RECEPTOR;
D O I：
10.1093/jnci/djp390
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1730 / 1730
页数：1
相关论文
共 50 条
  • [11] Her2 negative luminal breast carcinoma and Ki-67 evaluation
    Pavlakis, Kitty
    Vrekoussis, Thomas
    Tsipoura, Anna
    Tsenga, Artemis
    Arapantoni-Dadioti, Petroula
    Gavresea, Theofani
    Messini, Irini
    Barbounis, Vassilis
    BREAST, 2012, 21 (04): : 529 - 533
  • [12] Comparison of the hormone receptor status, HER2 status and Ki67 index between preoperative core needle biopsy and surgical specimens in invasive breast cancer
    Dobriakov, A.
    Opalenov, K.
    Salaeva, V.
    Poputchikova, E.
    Shvets, N.
    Antonov, M.
    Tokmakov, A.
    Cherkasova, Y.
    VIRCHOWS ARCHIV, 2020, 477 : S45 - S45
  • [13] Membranous and cytoplasmic staining of Ki67 is associated with HER2 and ER status in invasive breast carcinoma
    Faratian, Dana
    Munro, Alison
    Twelves, Christopher
    Bartlett, John M. S.
    HISTOPATHOLOGY, 2009, 54 (02) : 254 - 257
  • [14] Ki67 expression in triple negative and luminal A breast cancer
    Sullu, Y.
    Demirag, G. G.
    Ozen, N.
    VIRCHOWS ARCHIV, 2011, 459 : S81 - S82
  • [15] HER positivity in breast cancer is not associated with Ki67 of <5% and 50% of HER2 positive breast cancer are PR negative
    Javidparisijani, S.
    Kim, I.
    Pambuccian, S.
    Tang, P.
    VIRCHOWS ARCHIV, 2019, 475 : S245 - S245
  • [16] FEAT expression correlates with tumor size, PR status, HER2 expression, Ki67 index, and molecular subtype and predicts recurrence in breast cancer
    Wang, S. M.
    Ye, M.
    Zhou, J.
    Ni, S. M.
    Wei, Q. C.
    NEOPLASMA, 2017, 64 (01) : 123 - 130
  • [17] Questions about Ki67 staining in luminal breast cancer
    Kadri Altundag
    Breast Cancer Research and Treatment, 2018, 167 : 599 - 599
  • [18] Questions about Ki67 staining in luminal breast cancer
    Altundag, Kadri
    BREAST CANCER RESEARCH AND TREATMENT, 2018, 167 (02) : 599 - 599
  • [19] Correlation between Ki67 and Breast Cancer Prognosis
    Kontzoglou, Konstantinos
    Palla, Victoria
    Karaolanis, George
    Karaiskos, Ioannis
    Alexiou, Ioannis
    Pateras, Ioannis
    Konstantoudakis, Konstantinos
    Stamatakos, Michael
    ONCOLOGY, 2013, 84 (04) : 219 - 225
  • [20] Combined Use of cyclinD1 and Ki67 for Prognosis of Luminal-Like Breast Cancer Patients
    Hao, Junmei
    Zhang, Wenfeng
    Lyu, Yan
    Zou, Jiarui
    Zhang, Yunyun
    Lyu, Jiahong
    Zhang, Jianbo
    Xie, Shuishan
    Zhang, Cuiping
    Zhang, Jiandi
    Tang, Fangrong
    FRONTIERS IN ONCOLOGY, 2021, 11
12345